Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Clinical Microbiology Reviews
Robert W Shafer

Abstract

There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is caused by mutations in the protease and RT enzymes, the molecular targets of these drugs. Drug resistance mutations arise most often in treated individuals, resulting from selective drug pressure in the presence of incompletely suppressed virus replication. HIV-1 isolates with drug resistance mutations, however, may also be transmitted to newly infected individuals. Three expert panels have recommended that HIV-1 protease and RT susceptibility testing should be used to help select HIV drug therapy. Although genotypic testing is more complex than typical antimicrobial susceptibility tests, there is a rich literature supporting the prognostic value of HIV-1 protease and RT mutations. This review describes the genetic mechanisms of HIV-1 drug resistance and summarizes published data linking individual RT and protease mutations to in vitro and in vivo resistance to the currently available HIV drugs.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L A Kohlstaedt, T A Steitz
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C K ShihJ A Griffin
May 18, 1989·Nature·S Kwok, R Higuchi
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·P L Boyer, S H Hughes
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·D W RodgersS C Harrison
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T ShirasakaR Yarchoan
Apr 1, 1995·Nature Structural Biology·R EsnoufD Stuart
Dec 1, 1995·The Journal of Infectious Diseases·L M DemeterR C Reichman
Sep 15, 1995·The Journal of Biological Chemistry·J GroverP J Roughley
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M TisdaleB A Larder
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A Jacobo-MolinaP Clark

❮ Previous
Next ❯

Citations

May 2, 2006·Molecular Diagnosis & Therapy·Lara B Strick, Anna Wald
Jan 19, 2008·Analytical and Bioanalytical Chemistry·Michaela SchannéJörg D Hoheisel
Dec 15, 2004·Journal of Molecular Modeling·Xianfeng ChenRobert W Harrison
Feb 15, 2008·Journal of Computer-aided Molecular Design·Anna Maria AlmericoAntonino Lauria
Aug 11, 2005·Current HIV/AIDS Reports·Joel E Gallant
Dec 7, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Paul D NeuwaldPaul A Jorgensen
Feb 14, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Rami Kantor, David Katzenstein
May 16, 2009·Journal of the American Chemical Society·Vinciane BorsenbergerStefan Howorka
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jing ZhangJun S Liu
Aug 12, 2003·AIDS Research and Human Retroviruses·Eleonor BrandinJan Albert
Mar 6, 2004·AIDS Research and Human Retroviruses·Ron KaganPeter Heseltine
Mar 11, 2004·AIDS Research and Human Retroviruses·Frank A J KoningsPhillipe N Nyambi
Jan 15, 2005·AIDS Research and Human Retroviruses·Sarawut NukoolkarnWichet Leelamanit
Dec 7, 2006·AIDS Research and Human Retroviruses·Ricardo ParreiraAida Esteves
Aug 2, 2008·AIDS Research and Human Retroviruses·Halina KrowickaSeth H Pincus
Apr 30, 2009·AIDS Research and Human Retroviruses·Abraham Joseph KandathilGopalan Sridharan
Nov 26, 2008·AIDS Research and Human Retroviruses·Rebecca F Turcotte, Ronald T Raines
Feb 3, 2009·AIDS Research and Human Retroviruses·Maria TrignettiFrancesca Ceccherini-Silberstein
Mar 23, 2011·AIDS Research and Human Retroviruses·Bruna Coelho CarvalhoMariane Martins de Araújo Stefani
Jul 28, 2011·AIDS Research and Human Retroviruses·Alexsander Augusto da SilveiraMariane Martins de Araújo Stefani
Jul 21, 2011·AIDS Research and Human Retroviruses·Cillian F De GascunWilliam W Hall
Aug 21, 2013·AIDS Research and Human Retroviruses·Min Hyung KimJun Yong Choi
Oct 6, 2006·Bioinformatics·K DeforcheUNKNOWN non-B Workgroup
Jan 10, 2003·Nucleic Acids Research·Soo-Yon RheeRobert W Shafer
May 21, 2005·AIDS·David H Schwartz, Sujatha Iyengar
Oct 4, 2008·AIDS·Koen DeforcheUNKNOWN non-B Workgroup
Dec 6, 2011·HIV Medicine·A C CarvalhoH Barros
May 13, 2009·Antimicrobial Agents and Chemotherapy·Jie FangDaniel J Tenney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.